0.00Open1.15Pre Close0 Volume0 Open Interest165.00Strike Price0.00Turnover0.00%IV90.32%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry1.15Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma75.91Leverage Ratio--Theta--Rho--Eff Leverage--Vega
FEMSA Stock Discussion
• $Blueprint Medicines (BPMC.US)$ : Jefferies Upgrades to Buy from Hold - PT $78 (from $88)
• $CatchMark Timber Trust Inc (CTT.US)$ : Raymond James Upgrades to Market Perform from Underperform
• $Danaher (DHR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $310 (from $299)
• $Enanta Pharmaceuticals (ENTA.US)$ : Evercore ISI Upgrades to In Line from Underperform - PT $39 (from $35)
• $FEMSA (FMX.US)$ : Bradesco BBI Upgrades to Outperform f...
• $AGNC Investment Corp (AGNC.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $13 (from $13.50)
• $Esperion Therapeutics (ESPR.US)$ : JP Morgan Upgrades to Neutral From Underweight
• $Fortinet (FTNT.US)$ : Mizuho Securities Upgrades to Buy from Neutral - PT $350 (from $340)
• $Horizon Technology Finance (HRZN.US)$ : Compass Point Upgrades to Neutral From Sell
• $Momentive Global (MNTV.US)$ : Craig-Hallum Upgrades to Buy from Hold - PT $...
Tuesday, February 1, 2022
$Wells Fargo & Co (WFC.US)$ $Moderna (MRNA.US)$ $BioNTech (BNTX.US)$ $Enterprise Products (EPD.US)$ $FEMSA (FMX.US)$ $Intuit (INTU.US)$ $Sysco Corp (SYY.US)$ $Healthpeak Properties (PEAK.US)$
No comment yet